Undervalued Dividend Growth Stock of the Week: Bristol-Myers Squibb (BMY)
With a market-beating 3.6% yield, a recent 10%+ dividend raise, and the potential that shares are 15% undervalued, this high-quality dividend growth stock is a highly worthy long-term idea here.
Read More